Asia-Pacific Regulatory Approved Apps Market Outlook to 2033 – Clinical-Focused Apps and Indication Specific Mobile Apps

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$5995
Buy Report Download FREE Resources

Published: December 31, 2025 Report Code: GDME20614CRDB-ST

Select Item

GlobalData’s “Asia-Pacific Regulatory Approved Apps Outlook to 2033” is a comprehensive databook report, covering key market data on the Asia-Pacific Regulatory Approved Apps market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments –

The Asia-Pacific Regulatory Approved Apps Market report provides key information and data on:
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
• 2024 company share data for Regulatory Approved Apps Market.
• Global corporate-level profiles of key companies operating within the Asia-Pacific Regulatory Approved Apps Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

Asia-Pacific Regulatory Approved Apps is segmented as follows –

• Clinical-Focused Apps

• Indication Specific Mobile Apps

Reasons to Buy

The Asia-Pacific Regulatory Approved Apps Market report helps you to develop:

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

Otsuka Pharmaceutical Co Ltd

Table of Contents

1 Table of Contents

2 Introduction_x000D_

2.1 What Is This Report About?_x000D_

2.2 Regulatory Approved Apps Market Segmentation_x000D_

2.3 Definitions of Markets Covered in the Report_x000D_

3 Regulatory Approved Apps Market, Asia-Pacific_x000D_

3.1 Regulatory Approved Apps Market, Asia-Pacific, Revenue ($m), 2018-2033_x000D_

3.2 Regulatory Approved Apps Market, Asia-Pacific, Revenue ($m), 2018-2033_x000D_

3.3 Regulatory Approved Apps Market, Asia-Pacific, Volume (Units), 2018-2033_x000D_

3.4 Regulatory Approved Apps Market, Asia-Pacific, Volume (Units), 2018-2033_x000D_

3.5 Regulatory Approved Apps Market, Asia-Pacific, Company Share by Revenue ($m), 2024_x000D_

4 Regulatory Approved Apps Market, Australia_x000D_

4.1 Regulatory Approved Apps Market, Australia, Revenue ($m), 2018-2033_x000D_

4.1.1 Clinical-Focused Apps Market, Australia, Revenue ($m), by Segment, 2018-2033_x000D_

4.1.2 Indication Specific Mobile Apps Market, Australia, Revenue ($m), by Segment, 2018-2033_x000D_

4.2 Regulatory Approved Apps Market, Australia, Volume (Units), 2018-2033_x000D_

4.2.1 Clinical-Focused Apps Market, Australia, Volume (Units), by Segment, 2018-2033_x000D_

4.2.2 Indication Specific Mobile Apps Market, Australia, Volume (Units), by Segment, 2018-2033_x000D_

4.3 Regulatory Approved Apps Market, Australia, Average Price ($), 2018-2033_x000D_

4.4 Regulatory Approved Apps Market, Australia, Company Share by Revenue ($m), 2024_x000D_

5 Regulatory Approved Apps Market, China_x000D_

5.1 Regulatory Approved Apps Market, China, Revenue ($m), 2018-2033_x000D_

5.1.1 Clinical-Focused Apps Market, China, Revenue ($m), by Segment, 2018-2033_x000D_

5.1.2 Indication Specific Mobile Apps Market, China, Revenue ($m), by Segment, 2018-2033_x000D_

5.2 Regulatory Approved Apps Market, China, Volume (Units), 2018-2033_x000D_

5.2.1 Clinical-Focused Apps Market, China, Volume (Units), by Segment, 2018-2033_x000D_

5.2.2 Indication Specific Mobile Apps Market, China, Volume (Units), by Segment, 2018-2033_x000D_

5.3 Regulatory Approved Apps Market, China, Average Price ($), 2018-2033_x000D_

6 Regulatory Approved Apps Market, India_x000D_

6.1 Regulatory Approved Apps Market, India, Revenue ($m), 2018-2033_x000D_

6.1.1 Clinical-Focused Apps Market, India, Revenue ($m), by Segment, 2018-2033_x000D_

6.1.2 Indication Specific Mobile Apps Market, India, Revenue ($m), by Segment, 2018-2033_x000D_

6.2 Regulatory Approved Apps Market, India, Volume (Units), 2018-2033_x000D_

6.2.1 Clinical-Focused Apps Market, India, Volume (Units), by Segment, 2018-2033_x000D_

6.2.2 Indication Specific Mobile Apps Market, India, Volume (Units), by Segment, 2018-2033_x000D_

6.3 Regulatory Approved Apps Market, India, Average Price ($), 2018-2033_x000D_

7 Regulatory Approved Apps Market, Japan_x000D_

7.1 Regulatory Approved Apps Market, Japan, Revenue ($m), 2018-2033_x000D_

7.1.1 Clinical-Focused Apps Market, Japan, Revenue ($m), by Segment, 2018-2033_x000D_

7.1.2 Indication Specific Mobile Apps Market, Japan, Revenue ($m), by Segment, 2018-2033_x000D_

7.2 Regulatory Approved Apps Market, Japan, Volume (Units), 2018-2033_x000D_

7.2.1 Clinical-Focused Apps Market, Japan, Volume (Units), by Segment, 2018-2033_x000D_

7.2.2 Indication Specific Mobile Apps Market, Japan, Volume (Units), by Segment, 2018-2033_x000D_

7.3 Regulatory Approved Apps Market, Japan, Average Price ($), 2018-2033_x000D_

7.4 Regulatory Approved Apps Market, Japan, Company Share by Revenue ($m), 2024_x000D_

8 Regulatory Approved Apps Market, South Korea_x000D_

8.1 Regulatory Approved Apps Market, South Korea, Revenue ($m), 2018-2033_x000D_

8.1.1 Clinical-Focused Apps Market, South Korea, Revenue ($m), by Segment, 2018-2033_x000D_

8.1.2 Indication Specific Mobile Apps Market, South Korea, Revenue ($m), by Segment, 2018-2033_x000D_

8.2 Regulatory Approved Apps Market, South Korea, Volume (Units), 2018-2033_x000D_

8.2.1 Clinical-Focused Apps Market, South Korea, Volume (Units), by Segment, 2018-2033_x000D_

8.2.2 Indication Specific Mobile Apps Market, South Korea, Volume (Units), by Segment, 2018-2033_x000D_

8.3 Regulatory Approved Apps Market, South Korea, Average Price ($), 2018-2033_x000D_

9 Overview of Key Companies in Asia-Pacific Regulatory Approved Apps Market_x000D_

9.1 Otsuka Pharmaceutical Co Ltd_x000D_

9.1.1 Company Overview_x000D_

9.2 Stryker Corp_x000D_

9.2.1 Company Overview_x000D_

9.3 Medtronic Inc_x000D_

9.3.1 Company Overview_x000D_

9.4 DexCom Inc_x000D_

9.4.1 Company Overview_x000D_

9.5 Johnson & Johnson_x000D_

9.5.1 Company Overview_x000D_

10 Regulatory Approved Apps Market Pipeline Products_x000D_

11 Appendix_x000D_

11.1 Research Methodology_x000D_

11.1.1 Coverage_x000D_

11.1.2 Secondary Research_x000D_

11.1.3 Primary Research_x000D_

11.1.4 Market Modeling and Forecasting_x000D_

11.1.5 Company Share Analysis_x000D_

11.1.6 Benchmarking_x000D_

11.2 GlobalData Consulting_x000D_

11.3 Contact Us_x000D_

11.4 Disclaimer

Table

Table 1: Regulatory Approved Apps Market, Cross Country Comparison, Asia-Pacific, Revenue ($m), USD Constant, 2018-2033_x000D_

Table 2: Regulatory Approved Apps Market, Asia-Pacific, Revenue ($m), USD Constant, 2018-2033_x000D_

Table 3: Regulatory Approved Apps Market, Asia-Pacific, Volume (Units), 2018-2033_x000D_

Table 4: Regulatory Approved Apps Market, Asia-Pacific, Volume (Units), 2018-2033_x000D_

Table 5: Regulatory Approved Apps Market, Asia-Pacific, Company Share by Revenue ($m), 2024_x000D_

Table 6: Regulatory Approved Apps Market, Australia, Revenue ($m), USD Constant, 2018-2033_x000D_

Table 7: Clinical-Focused Apps Market, Australia, Revenue ($m), USD Constant, 2018-2033_x000D_

Table 8: Indication Specific Mobile Apps Market, Australia, Revenue ($m), USD Constant, 2018-2033_x000D_

Table 9: Regulatory Approved Apps Market, Australia, Volume (Units), 2018-2033_x000D_

Table 10: Clinical-Focused Apps Market, Australia, Volume (Units), 2018-2033_x000D_

Table 11: Indication Specific Mobile Apps Market, Australia, Volume (Units), 2018-2033_x000D_

Table 12: Regulatory Approved Apps Market, Australia, Average Price ($), 2018-2033_x000D_

Table 13: Regulatory Approved Apps Market, Australia, Company Share by Revenue ($m), 2024_x000D_

Table 14: Regulatory Approved Apps Market, China, Revenue ($m), USD Constant, 2018-2033_x000D_

Table 15: Clinical-Focused Apps Market, China, Revenue ($m), USD Constant, 2018-2033_x000D_

Table 16: Indication Specific Mobile Apps Market, China, Revenue ($m), USD Constant, 2018-2033_x000D_

Table 17: Regulatory Approved Apps Market, China, Volume (Units), 2018-2033_x000D_

Table 18: Clinical-Focused Apps Market, China, Volume (Units), 2018-2033_x000D_

Table 19: Indication Specific Mobile Apps Market, China, Volume (Units), 2018-2033_x000D_

Table 20: Regulatory Approved Apps Market, China, Average Price ($), 2018-2033_x000D_

Table 21: Regulatory Approved Apps Market, India, Revenue ($m), USD Constant, 2018-2033_x000D_

Table 22: Clinical-Focused Apps Market, India, Revenue ($m), USD Constant, 2018-2033_x000D_

Table 23: Indication Specific Mobile Apps Market, India, Revenue ($m), USD Constant, 2018-2033_x000D_

Table 24: Regulatory Approved Apps Market, India, Volume (Units), 2018-2033_x000D_

Table 25: Clinical-Focused Apps Market, India, Volume (Units), 2018-2033_x000D_

Table 26: Indication Specific Mobile Apps Market, India, Volume (Units), 2018-2033_x000D_

Table 27: Regulatory Approved Apps Market, India, Average Price ($), 2018-2033_x000D_

Table 28: Regulatory Approved Apps Market, Japan, Revenue ($m), USD Constant, 2018-2033_x000D_

Table 29: Clinical-Focused Apps Market, Japan, Revenue ($m), USD Constant, 2018-2033_x000D_

Table 30: Indication Specific Mobile Apps Market, Japan, Revenue ($m), USD Constant, 2018-2033_x000D_

Table 31: Regulatory Approved Apps Market, Japan, Volume (Units), 2018-2033_x000D_

Table 32: Clinical-Focused Apps Market, Japan, Volume (Units), 2018-2033_x000D_

Table 33: Indication Specific Mobile Apps Market, Japan, Volume (Units), 2018-2033_x000D_

Table 34: Regulatory Approved Apps Market, Japan, Average Price ($), 2018-2033_x000D_

Table 35: Regulatory Approved Apps Market, Japan, Company Share by Revenue ($m), 2024_x000D_

Table 36: Regulatory Approved Apps Market, South Korea, Revenue ($m), USD Constant, 2018-2033_x000D_

Table 37: Clinical-Focused Apps Market, South Korea, Revenue ($m), USD Constant, 2018-2033_x000D_

Table 38: Indication Specific Mobile Apps Market, South Korea, Revenue ($m), USD Constant, 2018-2033_x000D_

Table 39: Regulatory Approved Apps Market, South Korea, Volume (Units), 2018-2033_x000D_

Table 40: Clinical-Focused Apps Market, South Korea, Volume (Units), 2018-2033_x000D_

Table 41: Indication Specific Mobile Apps Market, South Korea, Volume (Units), 2018-2033_x000D_

Table 42: Regulatory Approved Apps Market, South Korea, Average Price ($), 2018-2033_x000D_

Table 43: Regulatory Approved Apps Market Pipeline Products_x000D_

Table 44: Total Number of Primary Research Participants, Digital Health Market, by Country

Figures

Figure 1: Regulatory Approved Apps Market, Cross Country Comparison, Asia-Pacific, Revenue ($m), USD Constant, 2018-2033_x000D_

Figure 2: Regulatory Approved Apps Market, Asia-Pacific, Revenue ($m), USD Constant, 2018-2033_x000D_

Figure 3: Regulatory Approved Apps Market, Asia-Pacific, Volume (Units), 2018-2033_x000D_

Figure 4: Regulatory Approved Apps Market, Asia-Pacific, Volume (Units), 2018-2033_x000D_

Figure 5: Regulatory Approved Apps Market, Asia-Pacific, Company Share (%), 2024_x000D_

Figure 6: Regulatory Approved Apps Market, Australia, Revenue ($m), USD Constant, 2018-2033_x000D_

Figure 7: Clinical-Focused Apps Market, Australia, Revenue ($m), USD Constant, 2018-2033_x000D_

Figure 8: Indication Specific Mobile Apps Market, Australia, Revenue ($m), USD Constant, 2018-2033_x000D_

Figure 9: Regulatory Approved Apps Market, Australia, Volume (Units), 2018-2033_x000D_

Figure 10: Clinical-Focused Apps Market, Australia, Volume (Units), 2018-2033_x000D_

Figure 11: Indication Specific Mobile Apps Market, Australia, Volume (Units), 2018-2033_x000D_

Figure 12: Regulatory Approved Apps Market, Australia, Company Share (%), 2024_x000D_

Figure 13: Regulatory Approved Apps Market, China, Revenue ($m), USD Constant, 2018-2033_x000D_

Figure 14: Clinical-Focused Apps Market, China, Revenue ($m), USD Constant, 2018-2033_x000D_

Figure 15: Indication Specific Mobile Apps Market, China, Revenue ($m), USD Constant, 2018-2033_x000D_

Figure 16: Regulatory Approved Apps Market, China, Volume (Units), 2018-2033_x000D_

Figure 17: Clinical-Focused Apps Market, China, Volume (Units), 2018-2033_x000D_

Figure 18: Indication Specific Mobile Apps Market, China, Volume (Units), 2018-2033_x000D_

Figure 19: Regulatory Approved Apps Market, India, Revenue ($m), USD Constant, 2018-2033_x000D_

Figure 20: Clinical-Focused Apps Market, India, Revenue ($m), USD Constant, 2018-2033_x000D_

Figure 21: Indication Specific Mobile Apps Market, India, Revenue ($m), USD Constant, 2018-2033_x000D_

Figure 22: Regulatory Approved Apps Market, India, Volume (Units), 2018-2033_x000D_

Figure 23: Clinical-Focused Apps Market, India, Volume (Units), 2018-2033_x000D_

Figure 24: Indication Specific Mobile Apps Market, India, Volume (Units), 2018-2033_x000D_

Figure 25: Regulatory Approved Apps Market, Japan, Revenue ($m), USD Constant, 2018-2033_x000D_

Figure 26: Clinical-Focused Apps Market, Japan, Revenue ($m), USD Constant, 2018-2033_x000D_

Figure 27: Indication Specific Mobile Apps Market, Japan, Revenue ($m), USD Constant, 2018-2033_x000D_

Figure 28: Regulatory Approved Apps Market, Japan, Volume (Units), 2018-2033_x000D_

Figure 29: Clinical-Focused Apps Market, Japan, Volume (Units), 2018-2033_x000D_

Figure 30: Indication Specific Mobile Apps Market, Japan, Volume (Units), 2018-2033_x000D_

Figure 31: Regulatory Approved Apps Market, Japan, Company Share (%), 2024_x000D_

Figure 32: Regulatory Approved Apps Market, South Korea, Revenue ($m), USD Constant, 2018-2033_x000D_

Figure 33: Clinical-Focused Apps Market, South Korea, Revenue ($m), USD Constant, 2018-2033_x000D_

Figure 34: Indication Specific Mobile Apps Market, South Korea, Revenue ($m), USD Constant, 2018-2033_x000D_

Figure 35: Regulatory Approved Apps Market, South Korea, Volume (Units), 2018-2033_x000D_

Figure 36: Clinical-Focused Apps Market, South Korea, Volume (Units), 2018-2033_x000D_

Figure 37: Indication Specific Mobile Apps Market, South Korea, Volume (Units), 2018-2033

Asia-Pacific Regulatory Approved Apps Market Outlook to 2033 – Clinical-Focused Apps and Indication Specific Mobile Apps standard reports
Currency USD
$5,995

Can be used by individual purchaser only

Most Popular
$11,990

Can be shared by unlimited users within one corporate location e.g. a regional office

$17,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Asia-Pacific Regulatory Approved Apps Market Outlook to 2033 – Clinical-Focused Apps and Indication Specific Mobile Apps was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Digital Health reports
Medical Devices
New
Medical Devices M&A Deals H1 2026 - Top Themes: Strategic…
$495 | July 2026
Medical Devices
New
AI-designed Materials: Market Trends and Innovations
$995 | July 2026
Medical Devices
New
Traditional Wound Management Market Size by Segments, Share, Regulatory, Reimbursement,…
$7,500 | June 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Asia-Pacific Regulatory Approved Apps Market Outlook to 2033 – Clinical-Focused Apps and Indication Specific Mobile Apps in real time.

  • Access a live Asia-Pacific Regulatory Approved Apps Market Outlook to 2033 – Clinical-Focused Apps and Indication Specific Mobile Apps dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more